51. One-step formation of lipid-polyacrylic acid-calcium carbonate nanoparticles for co-delivery of doxorubicin and curcumin
- Author
-
Koyo Nishida, Shintaro Fumoto, Naotaka Kuroda, Hirotaka Miyamoto, Yi Chen, and Jianqing Peng
- Subjects
Male ,Drug ,Combination therapy ,media_common.quotation_subject ,Acrylic Resins ,Pharmaceutical Science ,Nanoparticle ,One-Step ,02 engineering and technology ,Pharmacology ,Mice ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,polycyclic compounds ,Animals ,Humans ,Doxorubicin ,curcumin ,calcium carbonate ,Rats, Wistar ,media_common ,Polyacrylic acid ,Hep G2 Cells ,021001 nanoscience & nanotechnology ,lipid nanoparticle ,Lipids ,Rats ,polyacrylic acid ,Calcium carbonate ,chemistry ,030220 oncology & carcinogenesis ,Curcumin ,Nanoparticles ,0210 nano-technology ,medicine.drug ,Nuclear chemistry - Abstract
A doxorubicin (Dox) and curcumin (Cur) combination treatment regimen has been widely studied in pre-clinical research. However, the nanoparticles developed for this combination therapy require a consecutive drug loading process because of the different water-solubility of these drugs. This study provides a strategy for the “one-step” formation of nanoparticles encapsulating both Dox and Cur. We took advantage of polyacrylic acid (PAA) and calcium carbonate (CaCO3) to realise a high drug entrapment efficiency (EE) and pH-sensitive drug release using a simplified preparation method. Optimisation of lipid ratios and concentrations of CaCO3 was conducted. Under optimal conditions, the mean diameter of PEGylated lipid/PAA/CaCO3 nanoparticles with encapsulated Cur and Dox (LPCCD) was less than 100?nm. An obvious pH-sensitive release of both drugs was observed, with different Dox and Cur release rates. Successful co-delivery of Cur and Dox was achieved via LPCCD on HepG2 cells. LPCCD altered the bio-distribution of Dox and Cur in vivo and decreased Dox-induced cardiotoxicity. The current investigation has developed an efficient ternary system for co-delivery of Dox and Cur to tumours, using a “one-step” formation resulting in nanoparticles possessing remarkable pH-sensitive drug release behaviour, which may be valuable for further clinical studies and eventual clinical application., Journal of Drug Targeting, 25(8), pp.704-714; 2017
- Published
- 2017